BioNTech SE (BNTX) Retained Earnings (2018 - 2025)
BioNTech SE (BNTX) reported Retained Earnings of -$1.7 billion for Q4 2025, down 20.17% on a YoY basis from -$2.1 billion in Q4 2024, and up 1.84% sequentially from -$1.7 billion in Q3 2025.
BioNTech SE (BNTX) Retained Earnings (2018 - 2025) Analysis & Trends
BioNTech SE (BNTX) has 8 years of Retained Earnings data on file, last reported at -$1.7 billion in Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings fell 20.17% year-over-year to -$1.7 billion; the trailing twelve-month figure through Dec 2025 stood at -$1.7 billion (down 20.17% YoY), and the FY2025 full-year result was -$1.7 billion, down 16.64% from the prior year.
- Retained Earnings improved to -$1.7 billion in Q4 2025, from -$1.7 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $527.6 million in Q3 2022 to a low of -$1.7 billion in Q3 2025.
- A 5-year average of -$862.5 million and a median of -$1.0 billion in 2023 frame the typical range for Retained Earnings.
- Peak annual rise in Retained Earnings reached 126.32% in 2022, while the deepest fall reached 906.27% in 2022.
- Tracing BNTX's Retained Earnings over 5 years: stood at $107.4 million in 2021, then tumbled by 906.27% to -$866.1 million in 2022, then slipped by 22.32% to -$1.1 billion in 2023, then sank by 33.7% to -$1.4 billion in 2024, then retreated by 20.17% to -$1.7 billion in 2025.
- Business Quant data shows BNTX's Retained Earnings at -$1.7 billion in Q4 2025, -$1.7 billion in Q3 2025, and -$1.7 billion in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | BioNTech SE | 22.13 Bn | 22.13 Bn | 668.28 Mn | -1.70 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.70 Bn |
| Sep 30, 2025 | -1.73 Bn |
| Jun 30, 2025 | -1.67 Bn |
| Mar 31, 2025 | -1.52 Bn |
| Dec 31, 2024 | -1.42 Bn |
| Sep 30, 2024 | -1.47 Bn |
| Jun 30, 2024 | -1.12 Bn |
| Mar 31, 2024 | -1.03 Bn |
| Dec 31, 2023 | -1.06 Bn |
| Sep 30, 2023 | -984.96 Mn |
| Jun 30, 2023 | -982.75 Mn |
| Mar 31, 2023 | -921.79 Mn |
| Dec 31, 2022 | -866.09 Mn |
| Sep 30, 2022 | 527.63 Mn |
| Jun 30, 2022 | 137.44 Mn |
| Mar 31, 2022 | 123.12 Mn |
| Dec 31, 2021 | 107.42 Mn |
| Mar 31, 2021 | 54.40 Mn |
| Dec 31, 2020 | 488.36 Mn |
| Dec 31, 2019 | 5.34 Mn |